Literature DB >> 12147339

Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor.

Yiqing Feng1, John J Likos, Leiming Zhu, Harold Woodward, Grace Munie, Joseph J McDonald, Anna M Stevens, Carol P Howard, Gary A De Crescenzo, Dean Welsch, Huey Sheng Shieh, William C Stallings.   

Abstract

MMP-2 is a member of the matrix metalloproteinase family that has been implicated in tumor cell metastasis and angiogenesis. Here, we describe the solution structure of a catalytic domain of MMP-2 complexed with a hydroxamic acid inhibitor (SC-74020), determined by three-dimensional heteronuclear NMR spectroscopy. The catalytic domain, designated MMP-2C, has a short peptide linker replacing the internal fibronectin-domain insertion and is enzymatically active. Distance geometry-simulated annealing calculations yielded 14 converged structures with atomic root-mean-square deviations (r.m.s.d.) of 1.02 and 1.62 A from the mean coordinate positions for the backbone and for all heavy atoms, respectively, when 11 residues at the N-terminus are excluded. The structure has the same global fold as observed for other MMP catalytic domains and is similar to previously solved crystal structures of MMP-2. Differences observed between the solution and the crystal structures, near the bottom of the S1' specificity loop, appear to be induced by the large inhibitor present in the solution structure. The MMP-2C solution structure is compared with MMP-8 crystal structure bound to the same inhibitor to highlight the differences especially in the S1' specificity loop. The finding provides a structural explanation for the selectivity between MMP-2 and MMP-8 that is achieved by large inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147339     DOI: 10.1016/s0167-4838(02)00307-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  QM/MM Studies of the Matrix Metalloproteinase 2 (MMP2) Inhibition Mechanism of (S)-SB-3CT and its Oxirane Analogue.

Authors:  Jia Zhou; Peng Tao; Jed F Fisher; Qicun Shi; Shahriar Mobashery; H Bernhard Schlegel
Journal:  J Chem Theory Comput       Date:  2010-11-09       Impact factor: 6.006

2.  Conformational variability of matrix metalloproteinases: beyond a single 3D structure.

Authors:  Ivano Bertini; Vito Calderone; Marta Cosenza; Marco Fragai; Yong-Min Lee; Claudio Luchinat; Stefano Mangani; Beatrice Terni; Paola Turano
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

3.  Molecular docking and inhibition of matrix metalloproteinase-2 by novel difluorinatedbenzylidene curcumin analog.

Authors:  Aamir Ahmad; Afreen Sayed; Kevin R Ginnebaugh; Vivek Sharma; Anita Suri; Arundhati Saraph; Subhash Padhye; Fazlul H Sarkar
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

4.  Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization.

Authors:  Elisa Nuti; Lea Rosalia; Doretta Cuffaro; Caterina Camodeca; Chiara Giacomelli; Eleonora Da Pozzo; Tiziano Tuccinardi; Barbara Costa; Claudia Antoni; Laura Vera; Lidia Ciccone; Elisabetta Orlandini; Susanna Nencetti; Vincent Dive; Claudia Martini; Enrico A Stura; Armando Rossello
Journal:  ACS Med Chem Lett       Date:  2017-02-07       Impact factor: 4.345

5.  Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors.

Authors:  Jacob D Durrant; César A F de Oliveira; J Andrew McCammon
Journal:  Chem Biol Drug Des       Date:  2011-06-20       Impact factor: 2.817

6.  Comparison of Three Chain-of-States Methods: Nudged Elastic Band and Replica Path with Restraints or Constraints.

Authors:  Peng Tao; Milan Hodošček; Joseph D Larkin; Yihan Shao; Bernard R Brooks
Journal:  J Chem Theory Comput       Date:  2012-09-27       Impact factor: 6.006

7.  Inhibition of matrix metalloproteinase-2 by PARP inhibitors.

Authors:  Adrian C Nicolescu; Andrew Holt; Arulmozhi D Kandasamy; Pal Pacher; Richard Schulz
Journal:  Biochem Biophys Res Commun       Date:  2009-07-18       Impact factor: 3.575

8.  Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.

Authors:  Peng Tao; Jed F Fisher; Qicun Shi; Thom Vreven; Shahriar Mobashery; H Bernhard Schlegel
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

9.  Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT.

Authors:  Peng Tao; Jed F Fisher; Qicun Shi; Shahriar Mobashery; H Bernhard Schlegel
Journal:  J Phys Chem B       Date:  2010-01-21       Impact factor: 2.991

10.  Insights into the complex formed by matrix metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculations.

Authors:  Ilenia Giangreco; Gianluca Lattanzi; Orazio Nicolotti; Marco Catto; Antonio Laghezza; Francesco Leonetti; Angela Stefanachi; Angelo Carotti
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.